Central cannulation strategy for extent I thoracoabdominal aneurysm repair of chronic type B aortic dissection

Reilly D Hobbs1, Tyler J Wallen1, Caroline M Komlo1

  • 1Department of Cardiovascular Surgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.

Insights

Central aortic cannulation for thoracoabdominal aortic aneurysm repair is a safe alternative to peripheral femoral cannulation. This approach offers comparable early and midterm outcomes, making it a viable option for patients with compromised femoral vessels.

Area of Science:

  • Cardiovascular Surgery
  • Thoracic Surgery
  • Aortic Surgery

Background:

  • Thoracoabdominal aortic aneurysms (TAAA) with chronic type B dissection present complex surgical challenges.
  • Traditional cardiopulmonary bypass (CPB) cannulation strategies often involve peripheral femoral vessels.
  • Evaluating alternative cannulation sites is crucial for improving patient outcomes.

Purpose of the Study:

  • To compare the safety and efficacy of central aortic cannulation versus peripheral femoral cannulation for extent I TAAA repair in patients with chronic type B dissection.

Main Methods:

  • Retrospective review of patients undergoing extent I TAAA repair from 2002-2011.
  • Group I: Central aortic cannulation via left thoracotomy (n=28).
  • Group II: Peripheral femoral cannulation (n=31).
  • Both groups underwent deep hypothermic circulatory arrest.

Main Results:

  • Preoperative aortic dimensions were similar between groups.
  • Central cannulation (Group I) had significantly longer CPB times (240±37 min vs 174±68 min).
  • Early and midterm outcomes including mortality, stroke, paraplegia, reoperation for bleeding, tracheostomy rates, and length of stay were similar between groups.
  • 5-year actuarial survival was 84.6% for Group I and 77.6% for Group II (p=0.52).

Conclusions:

  • Central true lumen cannulation is an acceptable and safe alternative for extent I TAAA repair in chronic type B dissection.
  • This technique offers equivalent early and midterm outcomes compared to standard femoral cannulation.
  • It provides a valuable alternative for patients with diseased femoral vessels.
Abstract